Citation: Rr. Mehta et al., PLASMA C-ERBB-2 LEVELS IN BREAST-CANCER PATIENTS - PROGNOSTIC-SIGNIFICANCE IN PREDICTING RESPONSE TO CHEMOTHERAPY, Journal of clinical oncology, 16(7), 1998, pp. 2409-2416
Citation: Tj. Hieken et Tk. Dasgupta, MUTANT P53 EXPRESSION - A MARKER OF DIMINISHED SURVIVAL IN WELL-DIFFERENTIATED SOFT-TISSUE SARCOMA, Clinical cancer research, 2(8), 1996, pp. 1391-1395
Authors:
HIEKEN TJ
RONAN SG
FAROLAN N
SHILKAITIS AL
DASGUPTA TK
Citation: Tj. Hieken et al., BETA-1 INTEGRIN EXPRESSION - A MARKER OF LYMPHATIC METASTASES IN CUTANEOUS MALIGNANT-MELANOMA, Anticancer research, 16(4B), 1996, pp. 2321-2324
Authors:
HIEKEN TJ
FAROLAN M
RONAN SG
SHILKAITIS A
WILD L
DASGUPTA TK
Citation: Tj. Hieken et al., BETA-3 INTEGRIN EXPRESSION IN MELANOMA PREDICTS SUBSEQUENT METASTASIS, The Journal of surgical research, 63(1), 1996, pp. 169-173
Authors:
PISHA E
CHAI H
LEE IS
CHAGWEDERA TE
FARNSWORTH NR
CORDELL GA
BEECHER CWW
FONG HHS
KINGHORN AD
BROWN DM
WANI MC
WALL ME
HIEKEN TJ
DASGUPTA TK
PEZZUTO JM
Citation: E. Pisha et al., DISCOVERY OF BETULINIC ACID AS A SELECTIVE INHIBITOR OF HUMAN-MELANOMA THAT FUNCTIONS BY INDUCTION OF APOPTOSIS, Nature medicine, 1(10), 1995, pp. 1046-1051
Citation: Tj. Hieken et Tk. Dasgupta, CURRENT CLINICAL-PRACTICE - CUTANEOUS MELANOMA - HOW MUCH SURGERY IS ENOUGH - RESPONSE, Seminars in oncology, 22(2), 1995, pp. 19-19
Authors:
HIEKEN TJ
RONAN SG
FAROLAN M
SHILKAITIS AL
KIM DK
DASGUPTA TK
Citation: Tj. Hieken et al., BETA(1) INTEGRIN EXPRESSION IN MALIGNANT-MELANOMA PREDICTS OCCULT LYMPH-NODE METASTASES, Surgery, 118(4), 1995, pp. 669-675